EGFR and non-small cell lung carcinoma: 2.6. LDOC1 Downregulation Reduces Sensitivity to First-Generation EGFR-TKIs and Predicts Worse Outcomes in Patients with EGFRM NSCLC Who Are Treated with Gefitinib